csl on board- who else is watching

CSLs CSO Mr Andrew Cutherbertson stated today that CSL has been watching POHs development of its unique TPM transdermal delivery platform for some time- and are pleased to be undertaking this research collaboration. Ill bet they are pleased to be undertaling this collaboration. They have effectively bought themselves a front row seat to the biggest game in town at a massive discount. Dont get me wrong - this is good for both POH and CSL

So who else has been watching?? Probably everyone. I reckon POH will be in play shortly. Big Pharma cannot afford to see POH sell of licenses to regional players for bits and pieces of its drug portfolio while awaiting final Phase 3 results- these research collaborations for mature pipeline product are a clever way for Pharma to lock in deals with minimal risk to funds.